MoonLake Immunotherapeutics Cash Flow Statement 2020-2024 | MLTX

Fifteen years of historical annual cash flow statements for MoonLake Immunotherapeutics (MLTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-44.08$-64.51$-4.54$-0.09
$0.01$0.01$0$0
$7.51$10.18$-0.03$-0.01
$7.52$10.19$-0.03$-0.01
$-0.84$-0.07$0$0
$0$0$0$0
$1.58$-1.31$0$0
$-6.63$-2.88$0.16$-0.28
$-6.22$-1.58$3.96$-0.22
$-42.78$-55.89$-0.61$-0.32
$-0.28$-0.02$0$0
$0$0$0$0
$0$0$0$0
$-24.90$-32.32$0$0
$0$0$0$0
$-24.90$-32.32$0$0
$0$0$0$-115.00
$-25.18$-32.34$0$-115.00
$0$-15.00$0$0
$0$0$-0.06$0
$0$-15.00$-0.06$0
$482$0$0$113
$482$0$0$113
$0$0$0$0
$-2.75$135$0$3.95
$480$120$-0.06$117
$412$31.47$-0.67$1.34
$7.11$9.65$0$0
$0$0$0$0